Lakeway, NY -- (SBWIRE) -- 02/12/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
StemCells, Inc. (NASDAQ:STEM) jumped up 25.83% to $2.07 on a traded volume of 710k shares. The Company announced that the twelve-month data from the first patient cohort in the Company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate for chronic spinal cord injury continued to demonstrate a favorable safety profile and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted. The third patient remains stable.
Is STEM a Strong At New highs? Let’s Find out Here
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) increased 12.78% to $4.50. The Company announced that the Phase 3 trial of palifosfamide in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS. The Company will announce topline results from this trial during the last week of March 2013.
Is ZIOP a Strong Buying Opportunity After The Recent Slump? Find out Here
Michael Kors Holdings Ltd (NYSE:KORS) surged up 12.39% to $64.05 on a traded volume of 1.99 million shares. The Company announced third quarter results. Total revenue increased 70.4% to $636.8 million. Gross profit increased 72.8% to $383.5 million. Income from operations was $204.8 million and as a percentage of total revenue was 32.2%. Net income was $130.0 million or $0.64 per diluted share compared to net income of $39.0 million or $0.20 per diluted share in the third quarter of fiscal 2012.
Is KORS a Strong At New highs? Let’s Find out Here
Masco Corporation (NYSE:MAS) went up 8.09% to $19.23. The company announced fourth quarter results. Net sales from continuing operations increased 9% to $1.9 billion. North American sales increased 12% and international sales decreased 1%. Gross profit margins were 25.0% compared to 21.9%. Income from continuing operations was $0.04 per common share compared to $(0.09) per common share.
Is MAS a Strong Buying Opportunity After The Recent Slump? Find out Here
Avon Products, Inc. (NYSE:AVP) augmented 11.40% to $19.24. The Company reported fourth quarter loss of $162.2 million or 37 cents per share compared to loss of $400,000 or nil per share in the prior year period. The revenue fell 1% to $3 billion. On an adjusted basis, Avon had a profit from continuing operations of 37 cents per share, beating Wall Street analyst estimates by 10 cents.
Is AVP a Strong At New highs? Let’s Find out Here
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)